Vicente, David
Moffitt Cancer Center · Florida Hospital Cancer Institute · Hospital Universitario Virgen Macarena · Sarah Cannon · Tennessee Oncology
2 papers on CoChatORCID 0000-0001-9945-7008
Most cited papers
- Verified
Durvalumab after chemoradiotherapy in stage III non–small-cell lung cancer
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Yokoi, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2017) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 4,593
- Verified
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
Antonia, S. J., Villegas, A., Daniel, D., Vicente, D., Murakami, S., Hui, R., Kurata, T., Chiappori, A., Lee, K. H., de Wit, M., et al. (2018) · New England Journal of Medicine
Cancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Cited by 2,798
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free